Senti Biosciences Holdings SNTI
NASDAQ SNTI
$0.16 +0.02 (+11.81%)
At close: Nov 11, 2026 · 4:00 PM EST

Senti Biosciences Holdings (SNTI) Liabilities from Discontinued Operations (2022 - 2023)

Updated

Analysis

Senti Biosciences Holdings (SNTI) Liabilities from Discontinued Operations (2022 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Senti Biosciences Holdings 4.36 Mn -39.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 243,000.00
Sep 30, 2023 216,000.00
Dec 31, 2022 1.19 Mn
API Access

Senti Biosciences Holdings Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=SNTI&period=max&api_key=YOUR_API_KEY